Chelated Manganese Supplements segmentation by application isolates four usage domains: animal feed, human nutrition, agricultural fertilizers, and pharmaceuticals. Animal feed accounts for the largest share, approximately 45 % of market volume, because manganese is essential for enzymatic processes in livestock and poultry, and chelation improves absorption efficiency, reducing required inclusion rates. Human nutrition, contributing around 30 %, encompasses fortified foods, dietary supplements, and clinical nutrition products where bioavailable manganese supports antioxidant defenses and bone metabolism. Agricultural fertilizers represent roughly 20 % of sales; chelated manganese mitigates soil fixation and ensures root uptake in pH‑neutral to alkaline soils, a critical factor for cereal and fruit crops. The pharmaceutical segment remains modest at about 5 %, limited to prescription‑grade manganese chelates used in specific therapeutic protocols for manganese deficiency disorders. The proportional distribution illustrated in the accompanying pie chart underscores how application demand drives revenue allocation across the Chelated Manganese Supplements market, with animal‑feed dominance reflecting both scale and regulatory endorsement.